Résultats de la recherche - Michael J. Martens

  • Résultat(s) 1 - 8 résultats de 8
Affiner les résultats
  1. 1
    Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study

    Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant C... par Jurjen Versluis, Wael Saber, Harrison Tsai, Christopher J. Gibson, Laura W. Dillon, Asmita Mishra, Joseph P. McGuirk, Richard T. Maziarz, Peter Westervelt, Pranay S. Hegde, Devdeep Mukherjee, Michael J. Martens, Brent R. Logan, Mary M. Horowitz, Christopher S. Hourigan, Ryotaro Nakamura, Corey Cutler, R. Coleman Lindsley

    Publié 2023
    Accéder au texte intégral Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  2. 2
    Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

    Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome par Ryotaro Nakamura, Wael Saber, Michael J. Martens, Alyssa Ramirez, Bart L. Scott, Betül Oran, Eric Leifer, Roni Tamari, Asmita Mishra, Richard T. Maziarz, Joseph P. McGuirk, Peter Westervelt, Sumithira Vasu, Mrinal M. Patnaik, Rammurti T. Kamble, Stephen J. Forman, Mikkael A. Sekeres, Frederick R. Appelbaum, Adam Mendizabal, Brent R. Logan, Mary M. Horowitz, Corey Cutler

    Publié 2021
    Accéder au texte intégral Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  3. 3
    Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial

    Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial par Joseph Pidala, Mehdi Hamadani, Peter Dawson, Michael J. Martens, Amin M. Alousi, Madan Jagasia, Yvonne A. Efebera, Saurabh Chhabra, Iskra Pusic, Shernan G. Holtan, James L.M. Ferrara, John E. Levine, Marco Mielcarek, Claudio Anasetti, Joseph H. Antin, Javier Bolaños‐Meade, Alan Howard, Brent R. Logan, Eric Leifer, Theresa S. Pritchard, Mary M. Horowitz, Margaret L. MacMillan

    Publié 2019
    Accéder au texte intégral Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  4. 4
    SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

    SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study par Joshua A. Hill, Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V. Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul M. Armistead, Peter Westervelt, John M. McCarty, Joseph P. McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir A. Toor, Stephanie Waldvogel, Lee M. Greenberger, Jeffery J. Auletta, Mary M. Horowitz, Marcie L. Riches, Miguel‐Angel Perales

    Publié 2023
    Accéder au texte intégral Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  5. 5
    Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

    Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis par Javier Bolaños‐Meade, Mehdi Hamadani, Juan Wu, Monzr M. Al Malki, Michael J. Martens, Lyndsey Runaas, Hany Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Karilyn Larkin, Brian C. Shaffer, Najla El Jurdi, Alison W. Loren, Melhem Solh, Aric C. Hall, Amin M. Alousi, Omer Jamy, Miguel‐Angel Perales, Janny M. Yao, Kristy Applegate, Ami S. Bhatt, Leslie S. Kean, Yvonne A. Efebera, Ran Reshef, W. B. Clark, Nancy DiFronzo, Eric Leifer, Mary M. Horowitz, Richard J. Jones, Shernan G. Holtan

    Publié 2023
    Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  6. 6
    Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703

    Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Resu... par Shernan G. Holtan, Mehdi Hamadani, Juan Wu, Monzr M. Al Malki, Lyndsey Runaas, Hany Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Karilyn Larkin, Brian C. Shaffer, Najla H El Jurdi, Alison W. Loren, Melhem Solh, Aric C. Hall, Amin M. Alousi, Omer Jamy, Miguel‐Angel Perales, Janny M. Yao, Kristy Applegate, Ami S. Bhatt, Leslie S. Kean, Yvonne A. Efebera, Carrie L. Kitko, Ran Reshef, William Clark, Nancy DiFronzo, Lori Henderson, Richard J. Jones, Eric Liefer, Michael J. Martens, Mary M. Horowitz, Javier Bolaños‐Meade

    Publié 2022
    Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  7. 7
    Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR

    Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR par Kitsada Wudhikarn, Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda, Hemalatha G. Rangarajan, Muhammad Bilal Abid, Mohamed A. Kharfan‐Dabaja, Kristen M. Williams, Siddhartha Ganguly, Jo‐Anne H. Young, Akshay Sharma, Giancarlo Fatobene, Tania Jain, Christopher G. Kanakry, Dipenkumar Modi, Natalie S. Grover, Baheyeldin Salem, Marjorie Vieira Batista, Paschalis Vergidis, Dwight E. Yin, Amer Beitinjaneh, Amar H. Kelkar, Taiga Nishihori, Jennifer Holter‐Chakrabarty, Usama Gergis, Melody Smith, Zeinab El Boghdadly, Christopher E. Dandoy, Hemant S. Murthy, Anna R. Huppler, Miguel‐Angel Perales, Roy F. Chemaly, Laurel A. Thur, Marcie L. Riches, Jeffery J. Auletta

    Publié 2025
    Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:
  8. 8
    Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

    Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States par Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Ruta Brazauskas, Xiaochun Zhu, Kehinde Adekola, Mahmoud Aljurf, Karen K. Ballen, Ashish Bajel, Frédéric Baron, Minoo Battiwalla, Amer Beitinjaneh, Jean‐Yves Cahn, Mathew Carabasi, Yi‐Bin Chen, Saurabh Chhabra, Stefan O. Ciurea, Edward A. Copelan, Anita D’Souza, John Edwards, James M. Foran, César O. Freytes, Henry C. Fung, Robert Peter Gale, Sergio Giralt, Shahrukh K. Hashmi, Gerhard Hildebrandt, Vincent T. Ho, Ann A. Jakubowski, Hillard M. Lazarus, Marlise R. Luskin, Rodrigo Martino, Richard T. Maziarz, Philip L. McCarthy, Taiga Nishihori, Rebecca L. Olin, Richard F. Olsson, Attaphol Pawarode, Edward Peres, Andrew R. Rezvani, David A. Rizzieri, Bipin N. Savani, Harry C. Schouten, Mitchell Sabloff, Matthew D. Seftel, Sachiko Seo, Mohamed L. Sorror, Jeff Szer, Baldeep Wirk, William A. Wood, Andrew Artz

    Publié 2017
    Accéder au texte intégral Accéder au texte intégral
    Artigo
    Ajouter aux favoris
    Enregistré dans:

Outils de recherche: